Related by context. Frequent words. (Click for all words.) 58 squamous 57 chronic lymphocytic leukemia CLL 56 squamous cell 55 lymph node involvement 55 Hodgkin 55 IV melanoma 54 relapsing remitting 54 lymphomas 54 Non Hodgkin lymphoma 53 estrogen receptor negative 53 cell carcinoma 53 Metastatic 53 non Hodgkin lymphomas 53 nasopharyngeal cancer 52 relapsed refractory 52 follicular non 52 epirubicin 52 refractory multiple myeloma 52 neoplasms 52 brain metastases 52 HER2 negative 51 medullary thyroid cancer 51 myelosuppression 51 cell lymphomas 51 follicular lymphoma 51 gastrointestinal stromal tumors 51 myelodysplastic syndrome MDS 51 hematological malignancies 51 bladder cancers 51 Multiple myeloma 51 hematologic 51 HER2 positive metastatic breast 51 hematologic cancers 50 non squamous 50 bone metastasis 50 malignant pleural mesothelioma 50 fluorouracil 50 DLBCL 50 hematologic malignancies 50 lymphoma CTCL 50 FOLFIRI 50 relapsed refractory multiple myeloma 50 sarcomas 50 metastatic renal cell carcinoma 50 cell malignancies 50 polycythemia vera 50 interferon alfa 50 temsirolimus 50 adenocarcinoma 50 glioblastoma multiforme GBM 50 leukemias 50 glioblastoma 50 Glioblastoma 49 vandetanib 49 neoplastic 49 myelodysplastic syndromes MDS 49 chemoradiation 49 adenocarcinomas 49 chronic myelogenous leukemia CML 49 soft tissue sarcomas 49 myelodysplastic syndromes 49 chemotherapy regimens 49 Bortezomib 49 EGFR mutations 49 cutaneous T cell 49 Neutropenia 49 unresectable 49 neoplasm 49 vinorelbine 49 xenograft models 49 febrile neutropenia 49 EGFR inhibitors 49 mg/m2 49 dose cohorts 49 chronic lymphocytic leukemia 49 plus gemcitabine 49 cytogenetic response 49 adenoma 49 nab paclitaxel 49 chemoradiotherapy 49 hypercalcemia 48 hematological cancers 48 Osteosarcoma 48 axitinib 48 lung colorectal 48 malignancies 48 Alemtuzumab 48 distant metastases 48 neoadjuvant 48 Carcinoma 48 arsenic trioxide 48 Chronic Lymphocytic Leukemia 48 relapsing remitting multiple sclerosis 48 neuroendocrine tumors 48 cell lung cancer 48 Merkel cell carcinoma 48 mg BID 48 bortezomib 48 Non Hodgkin Lymphoma 48 androgen independent 48 etoposide